Anthrax-Related EID Journal Articles

EID Journal is a peer-reviewed CDC journal tracking trends and analyzing new and reemerging infectious disease issues around the world.

2014

• Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults
  Emerging Infectious Diseases 2014 Feb;20(2).
• Special Considerations for Treatment of Anthrax in Pregnant and Postpartum Women
  Emerging Infectious Diseases 2014 Feb;20(2).
• Lethal Factor and Anti-Protective Antigen IgG Levels Associated with Inhalation Anthrax, Minnesota, USA
  Emerging Infectious Diseases 2014 Feb;20(2).
• Investigation of Inhalation Anthrax Case, United States
  Emerging Infectious Diseases 2014 Feb;20(2).
• Human Cutaneous Anthrax, Georgia 2010–2012
  Emerging Infectious Diseases 2014 Feb;20(2).
• Low-Incidence, High-Consequence Pathogens
  Emerging Infectious Diseases 2014 Feb;20(2).

2007 – 2013

• Conference Report on Public Health and Clinical Guidelines for Anthrax
  Emerging Infectious Diseases 2008 Apr;14(4).

2005 – 2006

• Cutaneous Anthrax, Belgian Traveler
  Emerging Infectious Diseases 2006 Mar;12(3).
• HEPA/Vaccine Plan for Indoor Anthrax Remediation
  Emerging Infectious Diseases 2005 Jan;11(1).
• Demand for Prophylaxis after Bioterrorism-related Anthrax Cases, 2001
  Emerging Infectious Diseases 2005 Jan;11(1).

2003 – 2004

• Airborne Infection with Bacillus anthracis-from Mills to Mail
  Emerging Infectious Diseases 2004 Jun;10(6).
• Swab Materials and Bacillus anthracis Spore Recovery from Nonporous Surfaces
  Emerging Infectious Diseases 2004 Jun;10(6).
• Bacillus anthracis Incident, Kameido, Tokyo, 1993
  Hiroshi Takahashi, Paul Keim, Arnold F. Kaufmann, Christine Keys, Kimothy L. Smith, Kiyosu Taniguchi, Sakae Inouye, and Takeshi Kurata.
  Emerging Infectious Diseases 2004 Jan;10(1).
• Nonhemolytic, Nonmotile Gram-Positive Rods Indicative of Bacillus anthracis
  Dib EG, Dib SA, Korkmaz DA, Mobarakai NK, Glaser JB.
  Emerging Infectious Diseases 2003 Aug;9(8):1013-1015.
• Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001
  Holtz TH, Ackelsberg J, Kool JL, et al.
  Emerging Infectious Diseases 2003 Jun;9(6):689-692.
• Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001
  Griffith KS, Mead P, Armstrong GL, et al.
  Emerging Infectious Diseases 2003 Jun;9(6):681-688.
• Inactivation of Bacillus anthracis Spores
  Whitney EAS, Beatty ME, Taylor TH Jr, et al.
  Emerging Infectious Diseases 2003 Jun;9(6):623-627.
• An Ounce of Prevention Is a Ton of Work: Mass Antibiotic Prophylaxis for Anthrax, New York City, 2001
  Blank S, Moskin LC, Zucker JR.
  Emerging Infectious Diseases 2003 Jun;9(6):615-626.
• Endemic, Notifiable Bioterrorism-Related Diseases, United States, 1992-1999
  Chang M, Glynn MK, Groseclose SL.
  Emerging Infectious Diseases 2003 May;9(5):556-564.
• Endemic Gastrointestinal Anthrax in 1960s Lebanon: Clinical Manifestations & Surgical Findings
  Kanafani ZA, Ghossain A, Sharara AI, et al.
  Emerging Infectious Diseases 2003 May;9(5):520-526.

2001 – 2002

• Anthrax Bioterrorism: Lessons Learned & Future Directions
  Hughes JM, Gerberding JL.
  Emerging Infectious Diseases 2002 Oct;8(10):1013-1014.
• Public Health in the Time of Bioterrorism
  Perkins BA, Popovic T, Yeskey K.
  Emerging Infectious Diseases 2002 Oct;8(10):1015-1018.
• Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings
  Jernigan DB, Raghunathan PL, Bell BP, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1019-1028.
• First Case of Bioterrorism-Related Inhalational Anthrax in the United States, Palm Beach County, Florida, 2001
  Traeger MS, Wiersma ST, Rosenstein NE, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1029-1034.
• First Case of Bioterrorism-Related Inhalational Anthrax, Florida, 2001: North Carolina Investigation
  Maillard J-M, Fischer M, McKee KT Jr, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1035-1038.
• Opening a Bacillus anthracis-Containing Envelope, Capitol Hill, Washington, D.C.: The Public Health Response and Epidemiologic Investigation Related to the Opening of a Bacillus anthracis–Containing Envelope, Capitol Hill, Washington, D.C.
  Hsu VP, Lukacs SL, Handzel T, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1039-1043.
• Bacillus anthracis Aerosolization Associated with a Contaminated Mail Sorting Machine
  Dull PM, Wilson KE, Kournikakis B, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1044-1047.
• Epidemiologic Investigations of Bioterrorism-Related Anthrax, New Jersey, 2001
  Greene CM, Reefhuis J, Tan C, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1048-1055.
• Bioterrorism-Related Anthrax: International Response by the Centers for Disease Control & Prevention
  Polyak CS, Macy JT, Irizarry-De La Cruz M, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1056-1059.
• A Two-Component Direct Fluorescent-Antibody Assay for Rapid Identification of Bacillus anthracis
  De BK, Bragg SL, Sanden GN, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1060-1065.
• Inhalational Anthrax Outbreak among Postal Workers, Washington, D.C., 2001
  Dewan PK, Fry AM, Laserson K, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1066-1072.
• Surveillance for Anthrax Cases Associated with Contaminated Letters, New Jersey, Delaware, & Pennsylvania, 2001
  Tan CG, Sandhu HS, Crawford DC, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1073-1077.
• Bioterrorism-Related Anthrax Surveillance, Connecticut, September–December, 2001
  Williams AA, Parashar UD, Stoica A, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1078-1082.
• Environmental Sampling for Spores of Bacillus anthracis
  Teshale EH, Painter J, Burr GA, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1083-1087.
• Call-Tracking Data and the Public Health Response to Bioterrorism-Related Anthrax
  Mott JA, Treadwell TA, Hennessy TW, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1088-1092.
• Coordinated Response to Reports of Possible Anthrax Contamination, Idaho, 2001
  Tengelsen L, Hudson R, Barnes S, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1093-1095.
• Laboratory Response to Anthrax Bioterrorism, New York City, 2001
  Heller MB, Bunning ML, France MEB, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1096-1102.
• Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen
  Quinn CP, Semenova VA, Elie CM, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1103-1110.
• Molecular Subtyping of Bacillus anthracis and the 2001 Bioterrorism-Associated Anthrax Outbreak, United States
  Hoffmaster AR, Fitzgerald CC, Ribot E, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1111-1116.
• Sequencing of 16S rRNA Gene: A Rapid Tool for Identification of Bacillus anthracis
  Sacchi CT, Whitney AM, Mayer LW, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1117-1123.
• Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence
  Shepard CW, Soriano-Gabarro M, Zell ER, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1124-1132.
• Anthrax Postexposure Prophylaxis in Postal Workers, Connecticut, 2001
  Williams JL, Noviello SS, Griffith KS , et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1133-1137.
• Adherence to Antimicrobial Inhalational Anthrax Prophylaxis among Postal Workers, Washington, D.C., 2001
  Jefferds MS, Laserson K, Fry AM, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1138-1144.
• Surface Sampling Methods for Bacillus anthracis Spore Contamination
  Sanderson WT, Hein MJ, Taylor L, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1145-1151.
• Collaboration Between Public Health and Law Enforcement: New Paradigms and Partnerships for Bioterrorism Planning & Response
  Butler JC, Cohen ML, Friedman CR, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1152-1156.
• Collaboration between Public Health and Law Enforcement: The Constitutional Challenge
  Richards EP.
  Emerging Infectious Diseases 2002 Oct;8(10):1157-1159.
• Epidemic Anthrax in the Eighteenth Century, the Americas
  Morens DM.
  Emerging Infectious Diseases 2002 Oct;8(10):1160-1162.
• Epidemiologic Response to Anthrax Outbreaks: A Review of Field Investigations, 1950–2001
  Bales ME, Dannenberg AL, Brachman PS, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1163-1174.
• Night of Two Town Meetings
  Cartter ML.
  Emerging Infectious Diseases 2002 Oct;8(10):1175-1177.
• Letter: Evaluation and Validation of a Real-Time Polymerase Chain Reaction Assay for Rapid Identification of Bacillus anthracis
  Hoffmaster AF, Meyer RF, Bowen M, et al.
  Emerging Infectious Diseases 2002 Oct;8(10):1178-1181.
• Letter: Industry-Related Outbreak of Human Anthrax, Massachusetts, 1868
  Macher A.
  Emerging Infectious Diseases 2002 Oct;8(10):1182.
• Conference Summary: Bioterrorism-Related Bacillus anthracis Public Health Research Priorities
  Perkins BA, Ashford DA.
  Emerging Infectious Diseases 2002 Oct;8(10):1183.
• Use of Automated Ambulatory-Care Encounter Records for Detection of Acute Illness Clusters, Including Potential Bioterrorism Events
  Lazarus R, Kleinman K, Dashevsky I, et al.
  Emerging Infectious Diseases 2002 Aug;8(8):753-760.
• Clinical Issues in the Prophylaxis, Diagnosis, and Treatment of Anthrax
  Emerging Infectious Diseases 2002 Feb;8(2):222-225.

1999-2000

• Anthrax: A Possible Case History
  Inglesby TV.
  Emerging Infectious Diseases 1999 Jul-Aug;5(4):556-560.
• Applying Lessons Learned from Anthrax Case History to Other Scenarios
  Bartlett JG.
  Emerging Infectious Diseases 1999 Jul-Aug;5(4):561-563.